Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Homewood, Alabama 25 trials found
New Search
Filter
Trial Phase
Study Type
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
PHASE1INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
N/AOBSERVATIONAL Birmingham, Alabama
RECRUITING
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
PHASE1, PHASE2INTERVENTIONAL Birmingham, Alabama
RECRUITING
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
PHASE2INTERVENTIONAL Birmingham, Alabama +2 more
RECRUITING
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
NAINTERVENTIONAL Birmingham, Alabama +1 more
RECRUITING
Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach
NAINTERVENTIONAL Birmingham, Alabama +3 more
RECRUITING
Diet and Cognitive Training in Hematologic Cancer Survivors
NAINTERVENTIONAL Birmingham, Alabama
RECRUITING
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Improve Cancer-related Cognitive Impairment
NAINTERVENTIONAL Birmingham, Alabama
RECRUITING
PRE-ISPY Phase I/II Oncology Platform Program
PHASE1, PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type